Skip to content

Research on the Mechanism of Tiaochangfang Decoction in Treating Sepsis Based on the Balance of Intestinal Microflora-Short Chain Fatty Acids-Th17/Treg

Research on the Mechanism of Tiaochangfang Decoction in Treating Sepsis Based on the Balance of Intestinal Microflora-Short Chain Fatty Acids-Th17/Treg

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001660
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

ontrol group:Conventional Western Medicine Treatment
Treatment group:200ml of the intestinal Tiaochangfang decoction for enema + conventional Western medicine treatment

Sponsors

Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Age between 18 and 80 years old gender not limited; 2) It conforms to the internationally recognized diagnostic criteria for SEPSIS (SEPSIS 3.0).

Exclusion criteria

Exclusion criteria: 1) Severe primary diseases that affect survival include: uncontrolled malignant tumors with multiple metastases that cannot be resected blood diseases and HIV etc. 2) Patients with liver or kidney dysfunction whose SOFA score for either the liver or kidney is =3 points; 3) Those who have continuously used immunosuppressants or received organ transplants within the past six months; 4) Those who have participated in other clinical trials within 30 days; 5) Have undergone major surgery or suffered significant trauma within the recent period (within one month); 6) Pregnant and lactating women; 7)The condition is severe (SOFA=15 or APACHE II=30) and/or the patient refuses active treatment; Patients with a history of allergy or contraindications to the ingredients of the intestinal-regulating formula used in the study.

Design outcomes

Primary

MeasureTime frame
28-day case fatality rate;

Secondary

MeasureTime frame
The types and abundance of intestinal flora;IL-6;IL-17;Treg/Th17;Metabolites of intestinal flora;IL-10;

Countries

China

Contacts

Public ContactSu He

Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine

suhehuangyan@163.com13804715218

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026